TSG-6 in conditioned media from adipose mesenchymal stem cells protects against visual deficits in mild traumatic brain injury model through neurovascular modulation

Kumar Abhiram Jha,Mickey Pentecost,Raji Lenin,Jordy Gentry,Lada Klaic,Nobel Del Mar,Anton Reiner,Chuan He Yang,Lawrence M. Pfeffer,Nicolas Sohl,Rajashekhar Gangaraju
DOI: https://doi.org/10.1186/s13287-019-1436-1
2019-11-05
Abstract:Abstract Background Retinal inflammation affecting the neurovascular unit may play a role in the development of visual deficits following mild traumatic brain injury (mTBI). We have shown that concentrated conditioned media from adipose tissue-derived mesenchymal stem cells (ASC-CCM) can limit retinal damage from blast injury and improve visual function. In this study, we addressed the hypothesis that TNFα-stimulated gene-6 (TSG-6), an anti-inflammatory protein released by mesenchymal cells, mediates the observed therapeutic potential of ASCs via neurovascular modulation. Methods About 12-week-old C57Bl/6 mice were subjected to 50-psi air pulse on the left side of the head overlying the forebrain resulting in an mTBI. Age-matched sham blast mice served as control. About 1 μl of ASC-CCM (siControl-ASC-CCM) or TSG-6 knockdown ASC-CCM (siTSG-6-ASC-CCM) was delivered intravitreally into both eyes. One month following injection, the ocular function was assessed followed by molecular and immunohistological analysis. In vitro, mouse microglial cells were used to evaluate the anti-inflammatory effect of ASC-CCM. Efficacy of ASC-CCM in normalizing retinal vascular permeability was assessed using trans-endothelial resistance (TER) and VE-cadherin expression in the presence of TNFα (1 ng/ml). Results We show that intravitreal injection of ASC-CCM (siControl-ASC-CCM) but not the TSG-6 knockdown ASC-CCM (siTSG-6-ASC-CCM) mitigates the loss of visual acuity and contrast sensitivity, retinal expression of genes associated with microglial and endothelial activation, and retinal GFAP immunoreactivity at 4 weeks after blast injury. In vitro, siControl-ASC-CCM but not the siTSG-6-ASC-CCM not only suppressed microglial activation and STAT3 phosphorylation but also protected against TNFα-induced endothelial permeability as measured by transendothelial electrical resistance and decreased STAT3 phosphorylation. Conclusions Our findings suggest that ASCs respond to an inflammatory milieu by secreting higher levels of TSG-6 that mediates the resolution of the inflammatory cascade on multiple cell types and correlates with the therapeutic potency of the ASC-CCM. These results expand our understanding of innate mesenchymal cell function and confirm the importance of considering methods to increase the production of key analytes such as TSG-6 if mesenchymal stem cell secretome-derived biologics are to be developed as a treatment solution against the traumatic effects of blast injuries and other neurovascular inflammatory conditions of the retina.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?
### The problems that the paper attempts to solve This paper aims to explore the mechanism of TNF -stimulated gene -6 (TSG -6) secreted by Adipose Mesenchymal Stem Cells (ASCs) in protecting visual function through neurovascular regulation in a mild Traumatic Brain Injury (mTBI) model. Specifically, the researchers hypothesized that TSG -6 is a key component in ASC -conditioned medium (ASC -CCM) with therapeutic potential, and attempted to verify the following questions: 1. **Is TSG -6 a key protein in ASC -CCM that exerts anti -inflammatory effects and protects the integrity of the retinal barrier?** - The study compared the effects of ASC -CCM with and without TSG -6 on visual function in the mTBI mouse model by knocking down TSG -6 expression. 2. **The role of TSG -6 in inhibiting microglial cell activation**: - The study evaluated the role of TSG -6 in inhibiting the activation of BV2 cells (a mouse microglial cell line), especially its impact on the production of inflammatory factors such as nitric oxide (NO), IL -1β, and CD86. 3. **The role of TSG -6 in protecting the integrity of the endothelial barrier**: - The study evaluated the role of TSG -6 in protecting the integrity of the endothelial barrier in TNF -α -induced human retinal endothelial cells (HREC) in vitro, especially by measuring the changes in Trans -Endothelial Resistance (TER) and VE -cadherin expression. 4. **The role of TSG -6 in improving visual function after mTBI**: - The study evaluated the improvement effects of TSG -6 on visual acuity and contrast sensitivity in the mTBI mouse model through visual function tests such as optokinetic reflex measurement and electroretinogram measurement. ### Main conclusions The research results show that TSG -6 in ASC -CCM plays a key role in inhibiting microglial cell activation, protecting the integrity of the retinal barrier, and improving visual function after mTBI. Specifically: - **ASC -CCM after TSG -6 knockdown cannot effectively inhibit microglial cell activation** and cannot protect the integrity of the endothelial barrier either. - **ASC -CCM containing TSG -6 significantly improves the visual acuity and contrast sensitivity of mTBI mice**, while ASC -CCM with TSG -6 knockdown does not have this effect. These findings expand our understanding of the mesenchymal stem cell secretome and emphasize the potential therapeutic value of TSG -6 in combating mTBI and other neurovascular inflammatory diseases.